TLDR: Infinx, a leading provider of AI-powered solutions for patient access and revenue cycle management, has announced a strategic investment in Maverick AI, an artificial intelligence company specializing in real-time autonomous medical coding. This collaboration aims to revolutionize medical coding workflows by integrating deep learning AI, promising to reduce manual effort, enhance compliance, and accelerate revenue capture for healthcare providers.
Cupertino, CA – August 13, 2025 – Infinx, a prominent provider of AI-driven solutions for patient access and revenue cycle management, has made a significant strategic investment in Maverick AI. Maverick AI is an innovative artificial intelligence company focused on real-time autonomous medical coding, a critical component of the healthcare revenue cycle.
This partnership is set to transform medical coding by combining Infinx’s robust AI and automation platform with Maverick AI’s purpose-built, GenAI-powered autonomous agents. These agents are designed to deliver real-time clinical summarization, autonomous code assignment, and scalable workflow automation for healthcare organizations. The core objective is to bring deep learning AI to the forefront of coding workflows, enabling providers to significantly reduce manual effort, improve compliance, and accelerate revenue capture.
Jaideep Tandon, CEO of Infinx, emphasized the critical need for such advancements, stating, “There’s no question that medical coding is one of the biggest pain points in the revenue cycle today. Maverick’s team has developed an exceptional solution—AI that truly understands clinical context and delivers results with unprecedented speed and accuracy.” He added, “We’re excited to bring their real-time autonomous coding technology into our platform so our customers can work smarter, move faster, and spend less time chasing charts.”
Maverick AI’s platform, developed by a team of revenue cycle experts and machine learning engineers, is powered by a healthcare-tuned generative AI foundation. Its autonomous coding agents have been rigorously trained on millions of specialty-specific charts, ensuring high accuracy and efficiency. The system operates within a HIPAA-compliant, SOC 2-certified environment, guaranteeing both data security and scalability.
Yossi Shahak, Founder and CEO of Maverick AI, highlighted the collaborative benefits: “Partnering with Infinx allows us to rapidly scale the impact of real-time autonomous coding. Together, we’re solving one of the biggest pain points in the revenue cycle—medical coding delays and errors—by combining AI intelligence with operational expertise.”
Also Read:
- CelHive Ascends to Unicorn Status, Revolutionizing AI-Powered Workforces and Digital Productivity
- Titan Secures $74 Million Investment to Advance AI Platform and Expand Through MSP Acquisitions
The integration of this technology is expected to yield substantial benefits, including an 85%+ direct-to-bill rate, with approximately 9 out of 10 cases coded in seconds without human intervention. It also promises 95% coding accuracy, which will significantly reduce denial rates and ensure predictable reimbursement. Furthermore, the solution aims to eliminate coding backlogs and provide unlimited volume capacity, scaling seamlessly without the need for additional manpower.
